Used as a key intermediate in the synthesis of tyrosine kinase inhibitors, particularly in the development of anticancer agents. Its structure enables selective binding to enzyme targets involved in cell signaling pathways, making it valuable in pharmaceutical research for treating cancers such as lung and breast carcinoma. The compound's fluorinated aromatic system enhances metabolic stability and bioavailability, which are critical for effective drug design. It is primarily utilized in laboratory settings for optimizing lead compounds during drug discovery.